Cencora appoints Sanchez to board and Cencora stock commands USD 61.6 billion value

Published on 10/07/2026 at 14:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue hit USD 84.75 billion in the third quarter, up 5.10 percent year over year. Cencora stock costs EUR 283.25 on October 7, 2026 after EUR 280.95.

Luftbild eines modernen Pharma-Lagerzentrums mit Lieferfahrzeugen und Verladedocks — Cencora Inc. betreibt US15135B1017 ein großes Pharmadistributionszentrum mit Lastwagen Gabelstaplern und täglicher Medikamentenlogistik, Illustration mit AI erstellt.

Cencora Inc. (ISIN US03073E1055) appointed Robert E. Sanchez as an independent director effective October 1, 2026, while Cencora stock carried a USD 61.6 billion market value as of October 6, 2026. The board appointment adds logistics and public-company experience as the pharmaceutical distributor continues to expand its specialty platform.

Board expands to eleven members

According to Cencora on September 25, 2026, Sanchez joined the board as an independent director effective October 1, 2026. The company said his background includes serving as Ryder's executive chair and chief executive officer, with experience in operations, finance and technology.

The appointment increased Cencora's board from ten to eleven members. The related filing states that Sanchez had not been assigned to a board committee at the time of the appointment, keeping the immediate change focused on board capacity rather than a new operating role.

Third-quarter growth supports guidance

Cencora reported USD 84.75 billion in revenue for the third quarter of fiscal 2026, up 5.10 percent from the same quarter a year earlier, while adjusted earnings per share reached USD 4.48 against a USD 4.35 consensus estimate, according to MarketBeat on October 5, 2026.

Management raised fiscal 2026 adjusted earnings-per-share guidance to USD 17.75-17.95 from USD 17.70-17.90, according to Yahoo Finance in the transcript of the August 5, 2026 earnings call. Adjusted operating income grew 17 percent in the quarter, but the company retained a 4 percent to 6 percent full-year revenue growth range, leaving execution in specialty distribution and logistics central to the outlook.

Stock price and valuation

Cencora stock was trading at EUR 283.25 at Lang & Schwarz on October 7, 2026 at 2:40 p.m. CEST, up 0.82 percent versus the prior close of EUR 280.95. On the NYSE, the stock was last at USD 316.37 on October 6, 2026 at 4:00 p.m. ET, within its USD 244.82 to USD 377.54 52-week range.

The further course of trading is shown by the continuously updated real-time quote of Cencora stock.